According to NewAmsterdam Pharma Company's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 142.994. At the end of 2023 the company had a P/S ratio of 65.3.
Year | P/S ratio | Change |
---|---|---|
2023 | 65.3 | 664.6% |
2022 | 8.54 |